Listed

Enveric Biosciences, Inc.

ENVBNasdaqCIK 890821HealthcareFiscal year ends Dec 31

Reports and events: 398 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Enveric Biosciences, Inc., Reports and events
FiledFormWhat it isAccession number
2022-03-3116:43 ET10-KAnnual reportPeriod 2021-12-310001493152-22-008510
2022-03-1514:59 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-006846
2022-03-0117:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-005767
2022-02-1816:15 ET8-K3.01 Delisting notice0001493152-22-004959
2022-02-1511:07 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-004649
2022-02-0912:25 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-003573
2022-01-1915:14 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-001580
2021-12-3017:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-032874
2021-11-1816:05 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-21-029223
2021-11-1521:13 ET10-QQuarterly reportPeriod 2021-09-300001493152-21-028263
2021-10-0515:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-024612
2021-10-0507:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-024572
2021-09-1707:00 ET8-K2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-022964
2021-09-1416:57 ET8-K5.07 Shareholder vote results0001493152-21-022698
2021-09-0317:26 ET8-K8.01 Other events0001493152-21-022044
2021-08-1316:31 ET10-QQuarterly reportPeriod 2021-06-300001493152-21-019738
2021-07-0816:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-016459
2021-07-0616:07 ET8-K5.08 Item not in the standard list; 8.01 Other events0001493152-21-016224
2021-06-2916:05 ET8-K/A4.01 Change of auditor; 9.01 Financial statements and exhibits0001493152-21-015539
2021-06-2806:14 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001493152-21-015334
2021-06-0814:25 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-013803
2021-05-2417:23 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-012752
2021-05-2016:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-21-012349
2021-05-1717:15 ET10-QQuarterly reportPeriod 2021-03-310001493152-21-011946
2021-05-1416:05 ET8-K5.07 Shareholder vote results0001493152-21-011500
2021-04-1312:17 ETDEF 14AProxy statementPeriod 2021-04-130001493152-21-008618
2021-04-1212:09 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-21-008506
2021-04-0117:17 ET10-KAnnual reportPeriod 2020-12-310001493152-21-007757
2021-04-0108:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-21-007644
2021-03-2316:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-21-006621
2021-03-1116:30 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-005817
2021-02-2616:19 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-004933
2021-02-1216:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-003633
2021-02-1116:01 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-003373
2021-02-0909:16 ET8-K/A9.01 Financial statements and exhibits0001493152-21-003025
2021-01-1516:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-001161
2021-01-1317:25 ET8-K/A9.01 Financial statements and exhibits0001493152-21-000971
2021-01-1209:10 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-000824
2021-01-1107:42 ET8-K/A9.01 Financial statements and exhibits0001493152-21-000698
2021-01-0617:11 ET8-K3.01 Delisting notice; 4.01 Change of auditor; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-000337
2021-01-0617:10 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-000336
2020-12-2910:07 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-20-024425
2020-12-2317:29 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-20-024265
2020-12-1817:42 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-20-023958
2020-12-1516:05 ET8-K5.07 Shareholder vote results0001493152-20-023638
2020-11-1606:31 ET10-QQuarterly reportPeriod 2020-09-300001493152-20-021409
2020-11-0409:30 ETDEF 14AProxy statementPeriod 2020-11-040001493152-20-020444
2020-09-1608:38 ET8-K/A1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-20-017871
2020-09-1108:00 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-20-017593
2020-08-1416:22 ET10-QQuarterly reportPeriod 2020-06-300001493152-20-015855

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 20:02 ET. Listed shows no prices and gives no investment advice.